HARRIS C MARTIN 4

What Happened Harris C. Martin, a director of Colgate-Palmolive Co. (CL), was granted two awards on May 11, 2026: 1,556 shares as an annual director stock grant and a 2,424-share derivative award (an option-style grant). Both awards were reported with an acquisition price of $0.00, giving a reported acquisition value of $0 for each line on the Form 4 (these are compensation grants, not open-market purchases or sales).

Key Details

• Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (timely filing).
• Awards: 1,556 shares (stock grant, F1) and 2,424 derivative shares (stock option grant, F2).
• Reported price/value: $0.00 per share on the filing (compensation grant).
• Vesting/exercise: The option-style award becomes exercisable in equal annual installments over three years starting on the first anniversary of the May 11, 2026 grant date (F3).
• Shares owned after the transaction: not disclosed in the provided filing summary.

Context These are routine, annual director compensation awards (not a sale or open-market purchase). The 1,556-share grant is an outright equity award; the 2,424-share derivative is a time-vesting option-style grant that vests over three years, so it does not represent immediately liquid shares. Such grants are common for non-employee directors and are part of standard incentive compensation.